Market Cap (In CNY)
1.77 Billion
Revenue (In CNY)
134.59 Million
Net Income (In CNY)
-70.99 Million
Avg. Volume
997.16 Thousand
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 9.36-31.55
- PE
- -
- EPS
- -
- Beta Value
- 0.274
- ISIN
- CNE100004NR4
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Jun Yu
- Employee Count
- -
- Website
- https://www.gdkbio.com
- Ipo Date
- 2021-08-02
- Details
- Jiangsu gdk Biotechnology Co., Ltd., a biological company, engages in the scientific research, production, operation, and service of human vaccines. The company offers quadrivalent influenza virus split and lyophilized human rabies vaccines. Its product pipeline has coverage for the prevention of principal infectious diseases, including influenza, rabies, chickenpox, shingles, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.
More Stocks
-
2001
-
4180
-
6712
-
6971Kyocera Corporation
6971
-
6698
-
VPHIFValeo Pharma Inc.
VPHIF
-
VNUEVNUE, Inc.
VNUE
-
PTMPPT Mitra Pack Tbk
PTMP